SCN11A — NaV1.9

SCN11A (NaV1.9) is a lever-L1 non-opioid analgesic target. Its promoter reads γ = 1.3952, placing it on the firing-threshold scale at |hsp| = 0.634312; the intervention direction is to reduce inward Na⁺. The read is reproducible [V]; the clinical magnitude is open [O].

SCN11A is read from its human promoter by the same deterministic engine used across the map (nearest-neighbour stacking energy → γ = 1.3952; R19 scale → |hsp| = 0.634312). The read places the gene in lever L1; its selectivity is cited Layer-2 biology, and every clinical magnitude (potency, dose, efficacy, safety) is graded [O].

The read

SCN11A — NaV1.9 sits in the threshold map at γ = 1.3952, |hsp| = 0.634312 (barrier 0.486646). It belongs to lever L1; the intervention direction is to reduce inward Na⁺ (TTX-R subthreshold/resting).

selectivity (cited) nociceptor-selective (DRG); hard to express in vitro

burden Tier-3 channelopathy/neuropathic

Grades

Firewall. γ here is a read of promoter switch-threshold structure only — never this channel's activation voltage, a candidate's potency, a dosing quantity, an in-vivo selectivity, or a clinical effect. Those magnitudes are [O] open.

Source

Dib-Hajj 1998 PNAS 95:8963; Huang 2017 (SCN11A pain variants) · reproduce the read (engine)

See also: its lever · prioritisation · grading.